Accelus Receives U.S. FDA 510(k) Clearance for its FlareHawk TiHawk11 Interbody Fusio

[admin]

TiHawk11 Interbody Fusion System Accelus recently received U.S. FDA 510(k) Clearance for its TiHawk11, the latest addition to its FlareHawk portfolio of expandable interbody fusion devices. PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administr